Rare diseases
Investigational molecules
Locations
474 conditions with trials, the busiest first
1 133 trials across Europe, recruiting first
Study of anakinra safety and effectiveness given by injection under the skin in patients with cystic fibrosis
GermanyStudy on the Effects of Ozanimod for Children with Moderate to Severe Crohn's Disease Not Responding to Usual Treatments
BelgiumStudy of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors
FranceStudy on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis
BulgariaStudy on the Acceptability of Pancreas Powder for Patients with Cystic Fibrosis and Pancreatic Exocrine Insufficiency
GermanyStudy of E7386 and Pembrolizumab for Patients with Previously Treated Colorectal Cancer, Melanoma, or Hepatocellular Carcinoma
SpainStudy of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors
NorwayStudy on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome
FranceStudy of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression
AustriaStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
BelgiumStudy on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
AustriaStudy of Pembrolizumab for Patients with Locally Advanced, Unresectable, Non-Metastatic Colorectal Cancer
The NetherlandsThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
